non traditional Chinese medicine (non-TCM)

PreclinicalSmall molecule

HHenan University of Traditional Chinese Medicine

non traditional Chinese medicine (non-TCM) is one of 69 small molecule programs targeting Pneumonia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PneumoniaActive, not recruiting

Idiopathic Pulmonary FibrosisActive, not recruiting

PneumoniaPreclinical

Active, not recruiting

Idiopathic Pulmonary FibrosisPreclinical

Active, not recruiting

Competition

Competitive Landscape

547 competitors in Pneumonia

#DrugCompanyPhaseTrials

Primaxin

Pfizer

Preclinical

2 2

Acanya

Pfizer

Preclinical

1 3

Prevacid

Takeda

Preclinical

1 4

Primaquine

Sanofi

Preclinical

1 5

Avlosulfon

AAlmirall, S.A.

Preclinical

4 6

Gantanol

CConrado Roberto Hoffmann Filho

Preclinical

2 7

Primsol

CConrado Roberto Hoffmann Filho

Preclinical

2 8

Retrovir

BBp Consulting, Inc

Preclinical

2 9

Mycifradin

PPharmacia and Upjohn

Preclinical

1 10

Ofev

Boehringer Ingelheim

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Not yet recruiting

Respiratory Disease

NCT06577701

Not yet recruiting

Pneumonia

NCT06613659

Q4 2028

Not yet recruiting

Idiopathic Pulmonary Fibrosis

NCT07162870

Clinical

Trials by Indication[1]

Respiratory Disease1 trial

Respiratory Disease Cohort Studies of Chinese Medicine for COPD(RESEARCH-COPD)

Not yet recruiting·HHenan University of Traditional Chinese Medicine··NCT06577701·10,000 enrolled

Pneumonia1 trial

Cohort Study on the Treatment of Severe Pneumonia with Traditional Chinese Medicine

Not yet recruiting·HHenan University of Traditional Chinese Medicine··NCT06613659·1,016 enrolled

Idiopathic Pulmonary Fibrosis1 trial

Idiopathic Pulmonary Fibrosis Cohort of TCM

Not yet recruiting·HHenan University of Traditional Chinese Medicine··NCT07162870·1,000 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for non traditional Chinese medicine (non-TCM). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — non traditional Chinese medicine (non-TCM) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for non traditional Chinese medicine (non-TCM). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Henan University of Traditional Chinese Medicine company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: HHenan University of Traditional Chinese Medicine

non traditional Chinese medicine (non-TCM)

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Q4 2028

Trials by Indication[1]

Respiratory Disease1 trial

Pneumonia1 trial

Idiopathic Pulmonary Fibrosis1 trial

References

Drug Info

Quick Facts

Related News